ADAR1 Expression Level in Rectal Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

September 1, 2026

Conditions
Rectum Cancer, Adenocarcinoma
Interventions
GENETIC

Adenosine deaminase acting on RNA1

Previous studies have demonstrated that increased ADAR1 expression is associated with poor survival in gastric and metastatic colon cancer. In rectal cancer, however, the relationship between ADAR1 levels and TNT response in locally advanced disease has not been investigated. Another point is that ADAR1 can also be studied using immunohistochemistry; however, its sensitivity and specificity are low, so in our study, RNA will be isolated and analyzed using real-time PCR.

Trial Locations (1)

42090

RECRUITING

Necmettin Erbakan University Faculty of Medicine, Departmen of Medical Oncology, Konya

All Listed Sponsors
collaborator

Turkish Society of Medical Oncology

UNKNOWN

lead

Necmettin Erbakan University

OTHER